Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
All news
(page 14)
14 July 2026
Sonatrach launches 140,000 m3/day desalination plant construction in Ben M’Hidi, Skikda
Two-year build to supply Skikda industrial area and ADE; project managed by ADC with works executed by ENAC, both Sonatrach subsidiaries.
14 July 2026
Genentech’s Gazyva (obinutuzumab) granted FDA priority review for primary membranous nephropathy
FDA granted priority review for obinutuzumab in pMN after Phase III MAJESTY showed markedly higher complete remission vs tacrolimus; FDA decision expected Nov 2026.
14 July 2026
Olin and Huntsman: SEC Declares S‑4 Effective for Planned Merger
SEC declared the Form S‑4 effective; special shareholder meetings set for Aug 25; closing expected H1 2027; transaction targets >$400M in synergies and broader vertical integration.
14 July 2026
Velocys launches AlphaCore 400 to extend microchannel FT into larger SAF projects
New higher-capacity microchannel reactor doubles capacity vs AlphaCore 200 to enable larger, lower-cost SAF and synthetic-fuel projects.
14 July 2026
PCC SE: Revenue +5–10% to nearly €1bn and EBITDA +20%+ expected in FY2026
Forecasts revenue near €1bn, EBITDA rising over 20% to a three‑digit million, and a return to EBIT profit; Q2 figures due Aug 20, 2026.
14 July 2026
Nobian and Airengy to test AirBattery compressed-air storage in a Danish salt cavern
Pilot to assess storing surplus renewable electricity as compressed air in a Danish salt cavern for long-duration grid balancing and energy security.
News type
Project Updates and Milestones
New Projects and Expansions
Mergers, Acquisitions, and Partnerships
Innovation and Product Development
Operational Changes and Investments
Sustainability and Environmental Initiatives
Financial Performance and Strategy
Executive Appointments and Governance Changes
Regulatory and Compliance Updates
Workforce and Corporate Social Responsibility (CSR)
Crisis and Risk Management
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
14 July 2026
Evonik and evitria launch eviCHO CHO‑K1 transient expression kit
Ready-to-use CHO‑K1 transient expression kit simplifies lab workflows and speeds consistent protein production for early-stage biologics research.
14 July 2026
Mitsui Chemicals to establish MC Dental Holdings America as oral-care global HQ
New US holding will become the global headquarters for the group's oral care business after the Ultradent acquisition; establishment moved up to July 2026.
14 July 2026
BP Q2 2026 trading statement
Lower reported upstream volumes from seasonal Gulf maintenance and Middle East disruption; stronger oil and refining realizations; net debt cut to $22–23bn; post-tax impairments about $1bn.
14 July 2026
Topsoe and Sasol license G2L SAF technology to Allied Biofuels for Uzbekistan plant
License and engineering deal to supply G2L eSAF and bio‑SAF technology for a Khorezm plant producing about 300,000 t SAF/eSAF annually; FID 2027, commercial ops targeted 2030.
14 July 2026
Acelen Renewables and Bunge sign five-year certified soybean oil supply for SAF and HVO
Five-year supply of 300,000 t/yr certified soybean oil (total >1 Mt) for SAF and renewable diesel at a Bahia biorefinery due to start operations in 2029.
13 July 2026
John Cockerill Hydrogen begins electrolyzer production in Belfort and starts 40 MW Netherlands phase
First 5 MW electrolyzer stack assembled in Belfort; Aspach to produce eight electrolyzers (40 MW) for a Dutch project; 25 MW previously supplied to Belgium.
13 July 2026
Rivus Batteries raises €2 million to scale critical‑mineral‑free flow battery chemistry
€2m seed plus €2m in grants to scale an organic, critical‑mineral‑free flow battery electrolyte compatible with commercial flow battery hardware.
13 July 2026
Galp 2Q26 trading update and Moeve downstream talks
Moeve tie-up aimed for H2 2026; provisional 2Q26 shows 127 kboepd production, $16.8/boe refining margin and 2.3 GW renewables capacity.
13 July 2026
Eni and BMW Group agree use of Enilive HVOlution for BMW corporate fleets
Corporate fleets to run on 100% HVO diesel from renewable feedstocks with per-vehicle traceability and station coverage across Italy, Germany and Austria.
13 July 2026
EIB lends €450m to OMV for Bruck green hydrogen plant
140 MW electrolyser at Bruck will produce 23,000 t/yr renewable hydrogen, feed Schwechat refinery via 22 km pipeline, cutting direct CO₂ by up to 150,000 t/yr; operations due end‑2027.
13 July 2026
BASF adds three REDcert² biomass‑balanced additives for architectural coatings
Three REDcert²‑certified biomass‑balanced additives enable lower product carbon footprint for architectural coatings while retaining existing performance and formulation compatibility.
13 July 2026
Rompetrol Energy tests island-mode operation at Petromidia cogeneration plant
Plant can start and run without National Energy System power; tested with Transelectrica and Nuclearelectrica; capacity ~80 MWh and 180 t/h steam; can feed surplus to grid.
13 July 2026
OMV secures €450m EIB loan for 140 MW green hydrogen plant
Plant in Lower Austria will produce up to 23,000 t/yr of green hydrogen, start by end‑2027, supply Schwechat refinery and cut about 150,000 t CO2 annually.
13 July 2026
GSK’s Jemperli shows sustained clinical complete responses in dMMR/MSI‑H locally advanced rectal cancer
Interim phase II results met primary endpoint (cCR12); trial suggests some patients may avoid chemo, radiation and surgery. Data to be shared with regulators including for US accelerated review.
13 July 2026
AkzoNobel confirms Nippon Paint €7.5bn offer for Decorative Paints
Multiple conditional, non-binding proposals received; Boards say the offer undervalues the business and continue to support the Axalta merger.
13 July 2026
Takeda and Indonesia to build national plasma ecosystem for PDMPs
Fractionation license granted; $30M pilot to open plasma donation centers and assess local PDMP manufacturing, first donation center expected 2027.
13 July 2026
Sinopec completes reorganization of China Aviation Oil into wholly‑owned subsidiary
Reorganization finalised; the aviation fuel business is now a wholly‑owned second‑level subsidiary, with integration to accelerate building a world‑class aviation energy supplier and deepen Party‑led governance.
13 July 2026
PETRONAS and Shizuoka Gas renew 30‑year LNG partnership
SPA for ~0.84 MMT LNG over seven years starting 2032; adds supply flexibility and reliability and includes plans to explore decarbonisation collaboration.
13 July 2026
Lhyfe and Messer: 10-year renewable hydrogen supply deal and 30% equity in four sites
10-year offtake plus minority equity in four European renewable hydrogen sites; minimum volumes start in 2026 and ramp to several hundred tonnes per year.
11 July 2026
Sinopec completes reorganisation of China Aviation Oil
Reorganisation aims to strengthen aviation fuel supply security, accelerate SAF scale-up and integrate production-to-sales for greater international competitiveness.
11 July 2026
Novo Nordisk: denecimig (Mim8) shows positive long-term Phase 3 FRONTIER4 results in haemophilia A
Interim FRONTIER4 data show consistent safety and efficacy of denecimig across weekly, biweekly and monthly dosing, with low injection-site reactions and high zero-bleed rates.
10 July 2026
Técnicas Reunidas wins 932 MW Alberta power plant for META data centre
Consortium to build a 932 MW combined‑cycle gas plant in Alberta to power META’s large AI data centre; plant will include carbon capture and can be doubled to 1,864 MW.
10 July 2026
Merck: FDA approves KEYTRUDA and KEYTRUDA QLEX with Padcev for perioperative MIBC
FDA clears PD‑1 inhibitor plus antibody‑drug conjugate regimens with enfortumab vedotin as neoadjuvant and adjuvant therapy around cystectomy for adults with muscle‑invasive bladder cancer.
10 July 2026
Hansoh Pharma: Ris‑Rez (risvutatug rezetecan) ARTEMIS‑008 shows overall survival benefit in Chinese SCLC patients
Phase III trial met overall survival endpoint in advanced or relapsed small‑cell lung cancer in China, with consistent secondary benefits and no new safety signals.
← Previous
Next →